Mia's Feed
Medical News & Research

Study Links Toxic 9/11 Dust Exposure to Blood Cancers and Genetic Changes

Study Links Toxic 9/11 Dust Exposure to Blood Cancers and Genetic Changes

Share this article

Research links toxic dust from the 9/11 WTC disaster to genetic mutations in blood cells, increasing the risk of leukemia among first responders. The study highlights inflammation's role and potential targets for preventive treatment.

2 min read

A comprehensive study conducted by researchers at the Montefiore Einstein Comprehensive Cancer Center (MECCC) highlights a significant connection between toxic dust exposure during the 9/11 World Trade Center (WTC) disaster and increased risks of blood cancers, such as leukemia. The research suggests that first responders who inhaled the hazardous particulate matter from the collapsing towers developed specific genetic mutations in their blood-forming cells. These mutations, associated with a condition called clonal hematopoiesis (CH), are typically age-related but were found at elevated levels in exposed individuals, particularly among those under age 60.

CH is a precancerous state where blood stem cells harbor the same gene mutations, leading to increased inflammation and a higher likelihood of developing blood cancers. The study involved sequencing blood samples from nearly 1,000 WTC first responders, along with control groups of firefighters who were not at the site and unexposed individuals from the general population. Responders exposed to the toxic dust exhibited a nearly sixfold increase in the risk of developing leukemia if they had high levels of these genetic mutations.

Experimental studies in mice reinforced these findings, showing that WTC dust induces inflammation via a protein called IL1RAP, which promotes the growth of mutant blood cells. Interestingly, scientists discovered that knocking out the gene for IL1RAP in mice prevented the expansion of defective clones, pointing to a potential target for preventive therapies.

The research indicates that environmental toxins can accelerate biological aging and contribute to cancer development by promoting genetic mutations and inflammation. These findings underscore the importance of screening toxin-exposed populations for early signs of clonal hematopoiesis and exploring targeted treatments, such as IL1RAP inhibitors, to reduce cancer risk. The study broadens our understanding of how environmental disasters can have long-term health effects, informing strategies for prevention and intervention in affected communities.

Source: https://medicalxpress.com/news/2025-09-toxic-exposures-blood-cancers.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Maternal Selenium Levels During Pregnancy May Lower Risk of Childhood Streptococcal Infections

Higher selenium levels during pregnancy may help protect children from streptococcal infections, supporting immune development. Learn more about this significant study from Japan.

'Dimmer switch' drug candidates offer hope for safer nerve pain and ischemic disease treatments

New drug candidates targeting the A1 adenosine receptor show promise for safer treatment of neuropathic pain and ischemia-reperfusion injury, thanks to innovative allosteric modulator technology.

New Biomarker Advances Personalized Treatment for ER+ Breast Cancer Patients

Researchers identify a biomarker that could predict responsiveness to CDK4/6 inhibitors in ER+ breast cancer, paving the way for more personalized therapies and improved patient outcomes.